POLYETHYLENE GLYCOL 3350- polyethylene glycol 3350 powder, for solution 
GLENMARK THERAPEUTICS INC., USA

----------

Polyethelene Glycol 3350, Powder for Solution

Polyethylene Glycol 3350, Powder for Solution

Drug Facts

Active ingredient (in each dose) (Can only)

Polyethylene Glycol 3350, 17 g (cap filled to line)

Purpose

Osmotic Laxative

Active ingredient (in each dose) (Packet Only)

Polyethylene Glycol 3350, 17 g

Purpose

Osmotic Laxative

Use

relieves occasional constipation (irregularity)
generally produces a bowel movement in 1 to 3 days

Warnings

Allergy alert:

Do not use if you are allergic to polyethylene glycol

Do not use if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have

nausea, vomiting or abdominal pain
a sudden change in bowel habits that lasts over 2 weeks
irritable bowel syndrome

Ask a doctor or pharmacist before use if you are taking a prescription drug

When using this product you may have loose, watery, more frequent stools

Stop use and ask a doctor if

you have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse. These may be signs of a serious condition.
you get diarrhea
you need to use a laxative for longer than 1 week

If pregnant or breast-feeding, ask a health professional before use.

Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions (Can Only)

do not take more than directed unless advised by your doctor
the bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line (white section in cap)
adults and children 17 years of age and older:
o
use once a day
o
fill to top of white section in cap which is marked to indicate the correct dose (17 g)
o
stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink
o
do not combine with starch-based thickeners used for difficulty swallowing
o
ensure that the powder is fully dissolved before drinking
o
do not drink if there are any clumps
o
do not use more than 7 days
children 16 years of age or under: ask a doctor

Directions (Packet Only)

do not take more than directed unless advised by your doctor
adults and children 17 years of age and older:
o
use once a day
o
stir and dissolve one packet of powder (17 g) in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink
o
do not combine with starch-based thickeners used for difficulty swallowing
o
ensure that the powder is fully dissolved before drinking
o
do not drink if there are any clumps
o
do not use more than 7 days
children 16 years of age or under: ask a doctor

Other Information

store at 20° - 25°C (68° - 77°F)
tamper-evident: do not use if foil seal under cap, printed with "SEALED for YOUR PROTECTION" is missing, open or broken

Inactive ingredients

none

Questions or comments?

Call weekdays 9 AM to 5 PM at 1 (888) 721-7115

Polyethylene Glycol 3350 powder for solution increases frequency of bowel movements and softens the stool.

Distributed by

Glenmark Therapeutics Inc., USA

Mahwah, NJ 07430

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 72657-196-16Polyethylene Glycol 3350

Powder for Solution

Osmotic Laxative

Relieves Occasional Constipation (Irregularity)
Softens Stool
TAMPER-EVIDENT: do not use if printed foil seal under cap is missing, open or brokenUnflavoredf
Sugar Free
Dissolves in Any Beverage

45 ONCE-DAILY DOSES

NET WT 26.9 OZ (765 g) EACH

45s Label front

image1front

45s Label back

image2
image3
image4
POLYETHYLENE GLYCOL 3350 
polyethylene glycol 3350 powder, for solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72657-196
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Polyethylene Glycol 3350 (UNII: G2M7P15E5P) (Polyethylene Glycol 3350 - UNII:G2M7P15E5P) Polyethylene Glycol 335017 g  in 17 g
Product Characteristics
ColorWHITE (Colorless upon dissolution) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72657-196-16765 g in 1 CAN; Type 0: Not a Combination Product09/19/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20392809/19/2024
Labeler - GLENMARK THERAPEUTICS INC., USA (969085666)
Establishment
NameAddressID/FEIBusiness Operations
Strides Pharma Science Limited918513263ANALYSIS(72657-196) , MANUFACTURE(72657-196) , PACK(72657-196)

Revised: 12/2024
Document Id: 5aba6bb1-d25d-4901-8e9c-4cd4a3a06471
Set id: 5aba6bb1-d25d-4901-8e9c-4cd4a3a06471
Version: 1
Effective Time: 20241202
 
GLENMARK THERAPEUTICS INC., USA